Finasteride Cost in Idaho 2026: Cash Pay, Insurance, Medicaid, and Compounded Options

What Is Finasteride and Why Does Cost Vary So Much?

Finasteride is a type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). The FDA approved the 5 mg tablet (Proscar) for BPH in 1992 and the 1 mg tablet (Propecia) for male-pattern hair loss in 1997, and both approvals remain active on the FDA label [1]. Generic versions of both strengths entered the U.S. market after patent expiration and drove retail prices down sharply, which is why the out-of-pocket cost in Idaho can be as low as $12 per month at major pharmacy chains in 2026, while the brand-name product still carries a list price near $85 per month.

The gap between brand and generic pricing is not unusual in the U.S. drug market, but the gap between retail cash price and compounded finasteride price ($45/month through a 503A pharmacy) deserves explanation. Compounded formulations often include different delivery mechanisms, such as topical solutions or combination products, that are not commercially available as an FDA-approved product. A licensed prescriber must determine whether a compounded product is clinically appropriate for a specific patient before that route makes financial sense [2].

Kaufman et al. (1998, J Am Acad Dermatol, N=1,553 men) demonstrated that finasteride 1 mg daily over 2 years produced visible hair regrowth in 66% of participants and halted progression in an additional 23%, giving clinicians strong evidence to support long-term prescribing [3]. Long-term use is relevant to cost planning: men who respond to finasteride typically stay on it for years, so even small monthly differences compound over time.

Generic Finasteride Cash Prices at Idaho Pharmacies in 2026

Generic finasteride is the cheapest route for most Idaho residents. The average cash-pay price across Idaho retail pharmacies in 2026 is approximately $12 per month for a 30-tablet supply of 1 mg finasteride. Prices differ by pharmacy chain, so comparison shopping across Walgreens, Walmart, Costco, and local independent pharmacies in Boise, Meridian, Nampa, or Idaho Falls can save several dollars per fill [4].

Pharmacy discount programs expand the savings further. GoodRx, RxSaver, and the NeedyMeds drug discount database can reduce the price at certain Idaho pharmacies to as low as $7 to $10 for a 30-day supply of 1 mg generic finasteride. GoodRx is not insurance; it is a negotiated pricing program accepted at most Idaho retail pharmacies [5]. Presenting a GoodRx coupon at the pharmacy counter is free, and no membership is required.

The 5 mg generic tablet used for BPH follows similar pricing, often running $10 to $15 per month cash pay. Some patients prescribed 5 mg for BPH split tablets to approximate the 1 mg AGA dose, but tablet splitting should only be done under the explicit guidance of a prescribing clinician because splitting an unscored tablet changes the delivered dose unpredictably. The FDA provides guidance on tablet splitting at its consumer drug information pages [6].

A 90-day supply instead of a 30-day supply frequently lowers the per-unit cost at mail-order pharmacies operating in Idaho. Patients with a valid Idaho prescription can access mail-order programs through pharmacy benefit managers affiliated with most employer-sponsored plans.

Idaho Medicaid Coverage for Finasteride

Idaho Medicaid does not cover finasteride when prescribed for androgenetic alopecia. The state's Medicaid program, administered through the Idaho Department of Health and Welfare and managed-care partners, classifies AGA treatment as cosmetic and therefore outside the covered benefit. Patients seeking finasteride strictly for hair loss should expect to pay cash unless they have supplemental private insurance that includes this indication [7].

Coverage for the BPH indication (5 mg, Proscar generics) is handled differently. Idaho Medicaid managed-care plans may cover finasteride for BPH, but prior authorization is commonly required. The Endocrine Society's Clinical Practice Guideline on BPH pharmacotherapy notes that 5-alpha-reductase inhibitors are recommended for men with enlarged prostates and moderate-to-severe lower urinary tract symptoms, which supports prior authorization approval in most cases [8]. Patients should ask their prescriber to submit a prior authorization request citing the clinical indication, documented prostate volume, and AUA Symptom Score.

Idaho Medicaid members enrolled in the Fee-for-Service program rather than managed care should check the Idaho Medicaid preferred drug list (PDL) directly, as the PDL is updated quarterly and coverage status can shift. The most current PDL is published by the Idaho Division of Medicaid on the DHHS website [7].

Low-income Idaho residents who do not qualify for Medicaid but meet certain income thresholds may qualify for the federal Extra Help program (also called Low Income Subsidy) if they are also enrolled in Medicare Part D. Extra Help can reduce monthly prescription costs to $1.45 to $10.35 per fill in 2026, depending on income level [5].

Is Compounded Finasteride Legal in Idaho?

Compounded finasteride is legal in Idaho when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare individualized preparations not commercially available, provided they meet USP standards, operate under state pharmacy board licensure, and do not compound copies of commercially available products without clinical justification [9].

The Idaho State Board of Pharmacy licenses and inspects 503A pharmacies operating in the state. A prescription from a licensed Idaho practitioner (or an out-of-state practitioner with Idaho telehealth prescribing authority) is required before a 503A pharmacy may dispense a compounded finasteride product. No federal or state statute prohibits the compounding of finasteride itself; the drug does not appear on the FDA's list of drug products that may not be compounded under section 503A [9].

The most common compounded finasteride product in Idaho is a topical solution combining finasteride with minoxidil, which some prescribers favor to reduce systemic DHT suppression while delivering active drug to the scalp. Oral compounded capsules at custom doses (for example, 0.5 mg for patients sensitive to the standard 1 mg dose) are also prepared by Idaho 503A pharmacies. Compounded finasteride through a licensed 503A pharmacy currently costs around $45 per month in Idaho, compared to approximately $12 per month for the generic oral tablet, so the additional cost should reflect a clinically distinct product rather than simply a different packaging of the same formulation.

503B outsourcing facilities, by contrast, produce sterile bulk compounded products for hospital or clinical use and are regulated primarily by the FDA rather than state boards. Finasteride is not typically supplied through 503B facilities for outpatient hair loss or BPH treatment [10].

Finasteride Insurance Coverage in Idaho: Employer Plans, ACA Marketplace, and PBMs

Private insurance coverage for finasteride in Idaho depends on the indication, the insurer, and the specific formulary tier. For BPH (5 mg), most major commercial plans in Idaho (including Blue Cross of Idaho, Regence BlueShield of Idaho, and SelectHealth) cover generic finasteride on Tier 1 or Tier 2, often with a copay of $5 to $25 per month after the deductible is met [4].

For AGA (1 mg), coverage is inconsistent. Some employer-sponsored plans include it; others exclude it explicitly as a cosmetic drug. The fastest way to verify coverage is to call the member services number on the insurance card and ask specifically: "Is generic finasteride 1 mg for androgenetic alopecia covered under my formulary?" Request the tier and any prior authorization requirements during the same call.

ACA Marketplace plans sold on Your Health Idaho, the state's insurance exchange, follow similar patterns. ACA plans must cover the essential health benefits package, but hair loss treatments are not included in that package, so finasteride 1 mg coverage is at each insurer's discretion [11].

Pharmacy benefit managers (PBMs) such as Express Scripts, CVS Caremark, and OptumRx administer the drug benefit for most Idaho employer plans. These PBMs publish formularies online, and patients can search by drug name to see their cost-sharing before filling a prescription. Switching to a 90-day mail-order supply through the PBM often reduces the per-fill cost by 25% to 33% even on a Tier 1 generic.

How the Merck Patient Assistance and Generic Savings Programs Work in Idaho

Merck, the manufacturer of brand-name Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg), offers patient assistance through the Merck Patient Assistance Program for uninsured or underinsured patients who meet income requirements [12]. Eligible Idaho residents may receive brand-name Propecia or Proscar at no cost or reduced cost. Applications are submitted through the Merck Helps program and require income documentation and a physician certification.

For patients who do not qualify for the Merck patient assistance program but want to reduce cost at the pharmacy counter, several generic manufacturers of finasteride distribute savings cards through third-party coupon aggregators. These cards are accepted at most Idaho pharmacies and can reduce the cash price to the $7 to $12 range already achievable through GoodRx [5].

The Rx Outreach program, a nonprofit mail-order pharmacy, offers finasteride at low fixed prices to patients who meet income criteria, and ships to Idaho addresses. NeedyMeds.org maintains a searchable database of patient assistance programs, including those covering finasteride, and is updated regularly [5].

Patients using a Health Savings Account (HSA) or Flexible Spending Account (FSA) through an Idaho employer can pay for finasteride prescribed for BPH or AGA with pre-tax dollars, effectively reducing the real out-of-pocket cost by their marginal tax rate. This applies to both brand-name and generic versions when dispensed with a valid prescription.

Telehealth Prescribing of Finasteride in Idaho

Telehealth prescribing of finasteride is permitted in Idaho. The state's telehealth laws allow licensed Idaho practitioners to prescribe non-controlled medications, including finasteride, following a valid patient-provider relationship established through synchronous video or asynchronous platforms, provided the prescriber meets Idaho Code requirements for telehealth practice [13].

Multiple national telehealth platforms, including Hims, Ro, Keeps, and HealthRX, prescribe finasteride to Idaho residents. Typical workflow: the patient completes a medical history intake, uploads photos of scalp progression, and has a video or asynchronous consultation with a licensed prescriber. If appropriate, a prescription is issued and filled by a partner pharmacy or shipped directly. Monthly telehealth subscription costs for finasteride in Idaho through these platforms typically range from $20 to $50 per month, which bundles the prescriber fee and the medication cost together [4].

A practical comparison framework for Idaho patients choosing between access routes:

Route 1. Local retail pharmacy, generic, cash pay: Best for patients who already have a prescription and want the lowest possible per-tablet cost. Approximately $12/month. Use a GoodRx or RxSaver coupon.

Route 2. Telehealth platform subscription: Best for patients who do not have a prescriber and want a fully remote, end-to-end solution. Approximately $20 to $50/month including consultation. Convenient but slightly higher total cost than Route 1.

Route 3. Licensed 503A compounding pharmacy: Best for patients whose prescriber has determined that a commercially unavailable formulation (topical finasteride/minoxidil combination, custom dose) is clinically appropriate. Approximately $45/month. Not the right choice solely to save money over generic oral tablets.

Route 4. Insurance (employer or ACA plan): Best for patients whose plan covers finasteride for their indication. Verify tier before filling. Could reduce cost to $5 to $25/month copay.

Route 5. Medicaid (BPH only, prior auth): Best for Idaho Medicaid members with a documented BPH diagnosis, prostate volume data, and an AUA Symptom Score supporting 5-alpha-reductase inhibitor use. Submit prior authorization through the prescriber.

Idaho prescribers using the telehealth route should note that the Idaho Board of Medicine requires that a telehealth encounter generate a medical record equivalent in scope to an in-person encounter, and that prescribing decisions be documented with the same clinical rigor as any office-based prescription [13].

Clinical Efficacy Context: Why Long-Term Cost Planning Matters

Finasteride works slowly. In Kaufman et al. (1998), measurable hair count increases were detectable at 12 months, but peak benefit occurred between 24 and 36 months of continuous daily use [3]. Discontinuation reverses benefit: most men who stop finasteride lose the regained hair within 9 to 12 months, according to data from the original Propecia key trials submitted to the FDA [1].

This long treatment horizon means a $3 to $5 monthly difference between pharmacy options adds up to $36 to $60 per year, and over 5 years the difference between the cheapest cash-pay option ($12/month) and a telehealth platform bundle ($40/month) exceeds $1,680. Choosing the right access route at the start of therapy matters financially.

The McConnell et al. MTOPS trial (N=3,047, NEJM 2003) established that finasteride 5 mg reduced the risk of BPH clinical progression by 34% as monotherapy over 4 years, supporting long-term use for that indication as well [14]. For both AGA and BPH patients in Idaho, multi-year cost planning is not optional.

The American Academy of Dermatology's clinical guidelines for AGA note that finasteride 1 mg daily is a Level A recommendation for male AGA, and the guideline authors state: "Finasteride is effective, well tolerated, and should be considered first-line pharmacotherapy for men with androgenetic alopecia who have no contraindications" [15]. That endorsement supports long-term prescribing and reinforces the need to minimize access barriers, including cost.

Side Effect Awareness and Informed Prescribing

Finasteride carries an FDA-required post-market label update covering post-finasteride syndrome (PFS), a cluster of persistent sexual, neurological, and psychological adverse effects reported by some men after stopping or while taking the drug. The prevalence of persistent adverse effects is debated; the clinical trials reported sexual side effects in approximately 3.8% of finasteride 1 mg users versus 2.1% placebo at 1 year, with most resolving after discontinuation [1].

The FDA label also carries a warning that finasteride may reduce PSA levels by approximately 50% after 6 months of use at the 5 mg dose, which can confound prostate cancer screening. Clinicians and patients in Idaho should be aware of this effect when interpreting PSA results [1]. The FDA's MedWatch program accepts voluntary adverse event reports for finasteride at the FDA safety reporting portal [6].

Comparing Total Annual Costs: Idaho 2026 Summary

To make the numbers concrete: a 30-year-old Idaho man starting finasteride 1 mg for AGA in January 2026, paying cash at a Boise Walmart with a GoodRx coupon, may pay approximately $84 to $120 for the full year. The same patient using a national telehealth platform at $35/month would pay $420 per year. Over 10 years of continuous therapy, the difference exceeds $3,000.

For a 60-year-old Idaho man using finasteride 5 mg for BPH covered under a Blue Cross of Idaho employer plan at a $10 Tier 1 copay: annual cost is $120 after any deductible period. If the same man were uninsured and using cash pay at a local pharmacy: approximately $144 per year at $12/month, which is close enough that insurance status barely changes the equation for the generic.

These comparisons show that for BPH patients with insurance, the practical cost difference between insured and uninsured is small. For AGA patients, particularly those using compounded or telehealth-bundled products, the gap is significant.